GVR Report cover Wound Debridement Market Size, Share & Trends Report

Wound Debridement Market Size, Share & Trends Analysis Report By Product (Gels, Ultrasonic Devices), By Method (Surgical, Autolytic), By Wound Type, By End Use, By Mode of Purchase, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Sep, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-2-68038-462-8
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 123

Report Overview

The global wound debridement market size was valued at USD 3.97 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028. The high incidence of chronic conditions, such as pressure ulcers, diabetic foot ulcers, and other target wounds, the availability of reimbursement in developed economies, and changing lifestyles are anticipated to drive the market. Furthermore, increasing incidence of accidents such as road accidents, burns, and trauma events across the globe is anticipated to drive the market. Additionally, the widening base of the geriatric population and increasing initiatives by the governments and private organizations to raise awareness regarding wound care treatment are projected to work in favor of the market.

U.S. wound debridement market size, by wound type, 2018 - 2028 (USD Million)

The COVID-19 outbreak has created large-scale opportunities for local manufacturers. Due to the restrictions on movement at international borders, the supply chain of major players has been disrupted. This created opportunity for local players to enter the market and meet the unmet demand of end users. The rising number of cases has led to the shortage of medical supplies; thus, local players are manufacturing products on a larger scale to meet the growing need. To enhance their foothold in the market, key companies are adopting various plans and strategies to gain a greater market share. An important step that these players can take is to partner with relevant third-party vendors.

In addition, the increasing adoption of debridement products and techniques to heal the wound faster is propelling the market growth. The micro-organisms and the presence of toxins on the wound inhibit healing and may lead to infection. Debridement removes the dead or infected tissues from the wound to promote healing.

The rising incidence of ulcers is anticipated to further boost the market growth. As per the statistics by the American Diabetes Association, in 2014, about 2.0% of the population was affected with diabetic ulcers in the U.S. Similarly, about 600,000 people are affected by a venous ulcer in the U.S. every year. Therefore, awareness programs for wound care treatment are necessary. In addition, the presence of better healthcare facilities, the adoption of advanced wound care products, developing healthcare infrastructure, and reimbursement policies are driving the market.

Product Insights

Medical gauze and pads held the largest share of 22.83% in 2020. Medical gauzes help in maintaining moisture around the wound, which allows rapid healing. Since these wound care products enable faster healing, wound dressings are highly recommended for chronic wounds, such as diabetic ulcers, burn injuries, pressure ulcers, and other slow-healing wounds. Gauzes are majorly composed of substances such as collagen, hydrocolloids, hydrogels, foams, and alginates.

Gels held the second-largest share in 2020 owing to their increasing demand and wide range of applications in the treatment of various wounds. The ultrasonic devices segment is expected to expand at the highest CAGR during the forecast period. This is due to certain advantages such as the ability to kill microorganisms at the wound site without damaging the blood vessel. On the basis of product, the market is segmented into gels, ointments and creams, medical gauzes, surgical devices, ultrasonic devices, and others.

Gels maintain a moist wound environment and have certain benefits as compared to other products. Gels are amorphous and clear hydrogel majorly used for the treatment of sloughy and necrotic tissue in chronic wounds. Increasing cases of surgical wounds or Surgical Site Infection (SSI) among patients and rising incidence of chronic wounds, especially diabetic foot ulcers, are among major factors contributing to the segment growth.

Method Insights

The surgical wound debridement segment dominated the market in 2020 with a share of 27.12%. It is the fastest way of wound debridement procedure to achieve a clean wound bed, thereby contributing to the segment growth. The autolytic wound debridement segment is expected to expand at the highest CAGR of 6.7% during the forecast period. On the basis of method/procedure, the market is segmented into autolytic, enzymatic, surgical, mechanical, and others.

Autolytic debridement is the removal of necrotic debris and damaged tissues from a wound site by the body’s own endogenous enzymes that engulf specific components of body tissues/cells. This method is usually comfortable and effective, but it takes a longer time than other methods of debridement. However, if significant autolysis is not observed within 1-2 weeks, then another method of debridement is considered.

Wound Type Insights

The diabetic foot ulcers segment dominated the market in 2020 with a share of 32.89% owing to the increasing number of patients suffering from diabetic foot ulcers. The pressure ulcers segment is expected to expand at the highest CAGR during the forecast period owing to a rise in the prevalence of various diseases that require a prolonged hospital stay. On the basis of wound type, the market is segmented into diabetic foot ulcers, pressure ulcers, venous leg ulcers, burn wound, and others.

Diabetic foot ulcers are majorly caused due to uncontrolled diabetes mellitus and are among the most common types of chronic wounds. Diabetic ulcers are generally painless and require a prolonged hospital stay. The increasing incidence of diabetic foot ulcers across the globe is a major factor fueling the segment growth.

End-use Insights

The hospitals segment dominated the market in 2020 with a share of 55.56%. The homecare segment is expected to expand at the highest CAGR of 6.9% during the forecast period. In terms of end-use, the market is segregated into hospitals, homecare, and others.

Increasing incidence of chronic wounds, such as diabetic foot ulcers and venous leg ulcers, is a key factor driving the hospitals segment. Moreover, the incidence of chronic wounds is expected to increase with aging and may create a significant financial burden on society. It is estimated that more than USD 25 billion is spent by the healthcare system on treating wound-related complications every year in the U.S. In addition, according to the American Diabetes Association (ADA), more than 9-12 million people in America suffer from chronic ulcers. Thus, the increasing incidence of chronic diseases, especially diabetes, and the rising geriatric population across the globe are among key factors boosting the segment growth.

Mode of Purchase Insights

The prescription segment dominated the market in 2020 with a share of 58.57%. The OTC segment is estimated to emerge as the fastest-growing segment over the forecast period owing to the lower price and a surge in approvals for OTC medications by the regulatory authorities. On the basis of mode of purchase, the market is divided into prescription, over the counter, and others.

Global wound debridement market share, by mode of purchase, 2020 (%)

The increasing prevalence of chronic wounds, diabetic foot ulcers, necrotic wounds, pressure ulcers, venous ulcers, and burns globally is the key factor boosting the market growth. Moreover, an increase in launches of generic equivalents is contributing to the segment growth. For instance, collagenase topical, the generic name of Santyl, is the only prescription-based topical debriding agent. The adoption of these generic equivalents is rising, especially as these generics are proven to be as effective as their original counterparts. Moreover, it is less expensive than the original drugs, thus affordable for patients.

Regional Insights

North America dominated the market with a share of 38.40% in 2020. This can be attributed to the increasing number of surgeries, a rise in the cases of diabetes, and the presence of key players in the market. Asia Pacific is expected to witness the fastest growth from 2021 to 2028 owing to various factors such as the increasing geriatric population, improving healthcare infrastructure, and the presence of a large patient base in this region.

Progressive economy, reforms to improve infrastructure, high unmet needs of a large population, and the availability of skilled labor are expected to fuel the growth of the APAC market. For instance, the introduction of Goods and Services Tax (GST) in India is anticipated to reduce the tax burden and its cascading effect. This is further anticipated to improve the ease of doing business in India.

Key Companies & Market Share Insights

Key players in the market are involved in various strategic initiatives, such as collaborations, regional expansion, service portfolio expansion, mergers, and acquisitions, in order to gain a greater market share. Several hospitals outsource their wound care directly to market participants to carry out the process smoothly. For instance, Healogics offers an outpatient wound care facility to hospitals, which are intended for healing complex wounds. It aids in cost savings and enhances revenue generation. It also provides inpatient consults at more than 60 partner hospitals. Furthermore, in January 2021, the company launched Healogics 2021. This Healing program is aimed at helping patients and healthcare providers with resources to improve health, heal wounds, and avoid needless amputations. Such developments are positively impacting the market growth. Some prominent players in the global wound debridement market include:

  • Acelity L.P. Inc.

  •  Smith & Nephew

  •  B. Braun Melsungen AG

  •  Coloplast A/S

  •  ConvaTec Group

  •  Paul Hartmann

  •  Mölnlycke Health Care

  •  Lohmann & Rauscher

  •  Medline Industries

  •  Integra Lifesciences

Wound Debridement Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 4.20 billion

Revenue forecast in 2028

USD 6.35 billion

Growth Rate

CAGR of 6.1% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, method, wound type, end-use, mode of purchase, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Russia; Japan; China; Brazil; Mexico; South Africa; Saudi Arabia

Key Companies Profiled

Acelity L.P. Inc.; Smith & Nephew; B. Braun Melsungen AG; Coloplast A/S; ConvaTec Group; Paul Hartmann; Mölnlycke Health Care; Lohmann & Rauscher; Medline Industries; Integra Lifesciences

Report coverage

Revenue, competitive landscape, growth factors, and trends

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country and segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global wound debridement market report on the basis of product, method, wound type, end-use, mode of purchase, and region:

  • Product Outlook (Revenue, USD Million, 2016 - 2028)

    • Gels

    • Ointment & Creams

    • Surgical Devices

    • Medical Gauze & pads

    • Ultrasonic Devices

    • Others

  • Method Outlook (Revenue, USD Million, 2016 - 2028)

    • Autolytic

    • Enzymatic

    • Surgical

    • Mechanical

    • Others

  • Wound Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Pressure Ulcers

    • Diabetic Foot Ulcers

    • Venous Leg Ulcers

    • Burn Wound

    • Others

  • End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Hospitals

    • Homecare

    • Others

  • Mode of Purchase Outlook (Revenue, USD Million, 2016 - 2028)

    • Prescription

    • Over the Counter

    • Others

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

      • Russia

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.